Dr. Sam Sophan is CHC’s Manager of the MDR-TB Program and Medical Advisor, working with GHC since 2009 where he has supported CHC’s programs on TB, multi-drug resistant (MDR)-TB, HIV, and HIV/TB care. Dr. Sophan previously served as a physician at the National Pediatrics Hospital in Phnom Penh, Cambodia from 1993 until 2009.

At CHC, Dr. Sophan has served as the principal investigator to conduct a “Cross-sectional Study to Measure the Period Prevalence of M. tuberculosis Disease in Children Less than Five Years of Age in Cambodia”, funded by Aeras Global TB Vaccine Foundation. This study promoted a greater understanding of its complex diagnostic tools for TB in young children with and introduced GeneXpert for TB diagnosis for the first time in Cambodia (and Asia). From 2011 onward, Dr. Sophan has managed the drug-resistant TB (DR-TB) program that CHC piloted and initiated in Cambodia in 2006 in close collaboration with the National Centre for Tuberculosis and Leprosy Control (CENAT) and he has played a critical role in initiating the new shorter treatment regimes for DR-TB which have been a game changer for DR-TB treatment in Cambodia and globally. He has shared CHC’s model approaches and outstanding DR-TB outcomes and retrospective studies with national and international colleagues through presentations such as at the Union World Conferences on Lung Health, the Union Conferences in Asia Pacific Region and local conferences as well.

Dr. Sophan received his medical degree from Faculty of Medicine, University of Health Sciences, Phnom Penh, CAMBODIA in 1992 followed by a Diploma in Tropical Medicine and Hygeine from Mahidol University in Bangkok Thailand in 1996. He also received a certificate in Pediatric HIV Research in 2002 from Brown University and a certificate from the Training Course in Health Research at the University of Health Sciences in 2009.